Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays (Q36472432)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1 reference

based on heuristic

inferred from title

Lance A. Liotta

3

object named as

Lance A Liotta

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

author name string

Julia D Wulfkuhle

1

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Kirsten H Edmiston

2

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Emanuel F Petricoin

4

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

publication date

1 May 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Nature Clinical Practice Oncology

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

256-268

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Genomics and proteomics in cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

From signatures to models: understanding cancer using microarrays

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Application of DNA microarray technology in determining breast cancer prognosis and therapeutic response

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Proteomics in translational cancer research: toward an integrated approach

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Signaling--2000 and beyond

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Current two-dimensional electrophoresis technology for proteomics

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Automatic identification of proteins with a MALDI-quadrupole ion trap mass spectrometer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Large-scale analysis of the yeast proteome by multidimensional protein identification technology

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Experimental design and analysis of antibody microarrays: applying methods from cDNA arrays

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody arrays in cancer research

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein biochips: A new and versatile platform technology for molecular medicine

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical proteomics: personalized molecular medicine

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical proteomics: translating benchside promise into bedside reality

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein chip technology

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein arrays: the current state-of-the-art

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular profiling of human cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein microarrays and proteomics

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein microarrays: meeting analytical challenges for clinical applications.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Progress in protein and antibody microarray technology

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein microarrays as tools for functional proteomics

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Dimensionality is the issue: use of photoaptamers in protein microarrays

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent advances of protein microarrays.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigen arrays for antibody profiling

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Profiling bladder cancer using targeted antibody arrays

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Signal pathway profiling of prostate cancer using reverse phase protein arrays

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Laser capture microdissection

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Technology insight: Identification of biomarkers with tissue microarray technology

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein microarrays: molecular profiling technologies for clinical specimens

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Genomic and proteomic technologies for individualisation and improvement of cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of proteomic analysis to monitor responses to biological therapies

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Tyrosine kinases as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

New anticancer agents and therapeutic strategies in development for solid cancers: a clinical perspective

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Combining EGFR inhibitors with radiation or chemotherapy: will preclinical studies predict clinical results?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

A mathematical model of combination therapy using the EGFR signaling network

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Personalised medicine for cancer: from drug development into clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastrointestinal stromal tumors: a paradigm for molecularly targeted therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Towards molecular diagnosis and targeted therapy of lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

ERBB receptors and cancer: the complexity of targeted inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted therapies in breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors predicting response to EGFR tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor inhibitors in the treatment of non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

The preanalytic phase. An important component of laboratory medicine

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0485

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/NCPONC0485

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36472432&oldid=2145263738"